{"DataElement":{"publicId":"3288513","version":"1","preferredName":"Patient Medical History Non Muscle Invasive Bladder Cancer Stage","preferredDefinition":"Code to describe the stage of non-muscle invasive bladder cancer if the patient has a history of disease.","longName":"3288506v1.0:3288511v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3288506","version":"1","preferredName":"Patient Medical History Non Muscle Invasive Bladder Cancer","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._an account of all medical events and problems a person has experienced._An operation in which a term denies or inverts the meaning of another term or construction._Muscle; one of the contractile organs of the body._Marked by a tendency to spread especially into healthy tissue._A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","longName":"2466333v1.0:3288504v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2466333","version":"1","preferredName":"Patient Personal Medical History","preferredDefinition":"A person who requires medical care.:an account of all medical events and problems a person has experienced.","longName":"C16960:C18772","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Personal Medical History","conceptCode":"C18772","definition":"A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1015B737-0744-2BBB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-28","endDate":null,"createdBy":"PWEST","dateCreated":"2006-03-28","modifiedBy":"ONEDATA","dateModified":"2006-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3288504","version":"1","preferredName":"Negation Muscle Invasive Bladder Carcinoma","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:Muscle; one of the contractile organs of the body.:Marked by a tendency to spread especially into healthy tissue.:A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","longName":"C25594:C13056:C14159:C4912","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Muscle","conceptCode":"C13056","definition":"One of the contractile organs of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Bladder Carcinoma","conceptCode":"C4912","definition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE8049FC-D50C-16F2-E040-BB89AD4341E8","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"ONEDATA","dateModified":"2011-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE8049FC-D51D-16F2-E040-BB89AD4341E8","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by T.Lichtenberg. mc 10/5/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3288511","version":"1","preferredName":"Non Muscle Invasive Bladder Cancer Stage","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._Muscle; one of the contractile organs of the body._Marked by a tendency to spread especially into healthy tissue._A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3288511v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No Known history of non-muscle invasive bladder cancer","valueDescription":"No Known history of non-muscle invasive bladder cancer","ValueMeaning":{"publicId":"3288512","version":"1","preferredName":"No Known history of non-muscle invasive bladder cancer","longName":"3288512","preferredDefinition":"No Known history of non-muscle invasive bladder cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE8049FC-D5CE-16F2-E040-BB89AD4341E8","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE8049FC-D5E7-16F2-E040-BB89AD4341E8","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"ONEDATA","dateModified":"2011-10-04","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Tis Stage Finding","ValueMeaning":{"publicId":"3201442","version":"1","preferredName":"Breast Cancer pTis TNM Finding v6 and v7","longName":"3201442v1.00","preferredDefinition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pTis TNM Finding v6 and v7","conceptCode":"C48974","definition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EC4-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"MMADDINENI","dateModified":"2023-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE8049FC-D5F1-16F2-E040-BB89AD4341E8","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"ONEDATA","dateModified":"2011-10-04","deletedIndicator":"No"},{"value":"T1","valueDescription":"T1 Stage Finding","ValueMeaning":{"publicId":"3201424","version":"1","preferredName":"T1 Stage Finding","longName":"3201424","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3C32-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE8049FC-D5FB-16F2-E040-BB89AD4341E8","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"ONEDATA","dateModified":"2011-10-04","deletedIndicator":"No"},{"value":"Ta","valueDescription":"Ta Stage Finding","ValueMeaning":{"publicId":"3205588","version":"1","preferredName":"Ta Stage Finding","longName":"3205588","preferredDefinition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pTa TNM Finding","conceptCode":"C96025","definition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EC6B910-A661-E8D4-E040-BB89AD43022D","latestVersionIndicator":"Yes","beginDate":"2011-03-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE8049FC-D605-16F2-E040-BB89AD4341E8","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"ONEDATA","dateModified":"2011-10-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3288510","version":"1","preferredName":"Negation Muscle Invasive Bladder Carcinoma Stage","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:Muscle; one of the contractile organs of the body.:Marked by a tendency to spread especially into healthy tissue.:A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3288510v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Muscle","conceptCode":"C13056","definition":"One of the contractile organs of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Bladder Carcinoma","conceptCode":"C4912","definition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE8049FC-D5A7-16F2-E040-BB89AD4341E8","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"ONEDATA","dateModified":"2011-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE8049FC-D5B8-16F2-E040-BB89AD4341E8","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"COOPERM","dateModified":"2011-10-05","changeDescription":"Released per approval by T.Lichtenberg. mc 10/5/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If patient has a history of n","type":"Preferred Question Text","description":"If patient has a history of non-muscle invasive bladder cancer","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE8049FC-D61B-16F2-E040-BB89AD4341E8","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"TSESU","dateModified":"2018-07-13","changeDescription":"Released per approval by T.Lichtenberg. mc 10/5/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}